NPI: 1053370122 · NEW ORLEANS, LA 70115 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,671 | $131K |
| 2019 | 6,724 | $141K |
| 2020 | 8,260 | $79K |
| 2021 | 5,598 | $210K |
| 2022 | 9,294 | $132K |
| 2023 | 4,200 | $259K |
| 2024 | 1,852 | $221K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 12,622 | 1,572 | $1.15M | |
| Q4081 | Epoetin alfa, 100 units esrd | 18,255 | 1,132 | $21K |
| J1756 | Iron sucrose injection | 852 | 190 | $792.32 |
| 83550 | 542 | 384 | $0.00 | |
| A4657 | Syringe w/wo needle | 4,366 | 1,334 | $0.00 |
| 82728 | 473 | 336 | $0.00 | |
| 82607 | 13 | 12 | $0.00 | |
| J1270 | Injection, doxercalciferol | 939 | 110 | $0.00 |
| 82306 | 29 | 25 | $0.00 | |
| 90674 | 16 | 12 | $0.00 | |
| G0499 | Hepb screen high risk indiv | 80 | 25 | $0.00 |
| 82746 | 13 | 12 | $0.00 | |
| 83540 | 541 | 383 | $0.00 | |
| 85048 | 1,142 | 707 | $0.00 | |
| 85041 | 1,157 | 719 | $0.00 | |
| 83970 | 1,356 | 880 | $0.00 | |
| J0887 | Epoetin beta esrd use | 65 | 29 | $0.00 |
| 82108 | 18 | 14 | $0.00 | |
| 85045 | 120 | 102 | $0.00 |